Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy.

[1]  G. Wagner,et al.  A comparison of paramedic versus basic emergency medical care of patients at high and low risk during acute myocardial infarction. , 1988, Journal of the American College of Cardiology.

[2]  F. Van de Werf,et al.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. , 1988, BMJ.

[3]  M. Sherrid,et al.  OUT-OF-HOSPITAL, PARAMEDIC ADMINISTERED STREPTOKINASE FOR ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[4]  L. Bossaert,et al.  Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. , 1988, Critical care medicine.

[5]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[6]  R. Califf,et al.  Helicopter transport of patients during acute myocardial infarction. , 1988, The American journal of cardiology.

[7]  A. Jaffe,et al.  Recent changes in management of acute myocardial infarction: implications for emergency care physicians. , 1988, Journal of the American College of Cardiology.

[8]  F. Sheehan,et al.  The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. , 1988, Circulation.

[9]  J. Strang,et al.  DRUG ABUSE STRATEGIES , 1988, The Lancet.

[10]  T. Feldman,et al.  Cellular telephone transmission of 12-lead electrocardiograms from ambulance to hospital. , 1987, The American journal of cardiology.

[11]  M. Gotsman,et al.  PREHOSPITAL CORONARY THROMBOLYSIS: A NEW STRATEGY IN ACUTE MYOCARDIAL INFARCTION , 1987, Thrombosis and Haemostasis.

[12]  P. Barriot,et al.  ACHIEVEMENT OF THROMBOLYSIS AT HOME IN CASES OF ACUTE MYOCARDIAL INFARCTION , 1987, The Lancet.

[13]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[14]  P. Serruys,et al.  Thrombolytic therapy for acute coronary obstruction: status in 1986. , 1986, Cardiologia.

[15]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[16]  M. Gotsman,et al.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.

[17]  R. Lewis,et al.  Reduction of mortality from prehospital myocardial infarction by prudent patient activation of mobile coronary care system. , 1982, American heart journal.

[18]  T. Waterston FLUIDS FOR DIARRHŒA IN YOUNG CHILDREN , 1977, The Lancet.

[19]  H. Wisniewski,et al.  IMMUNOSUPPRESSION BY LINOLEIC ACID , 1975, The Lancet.

[20]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[21]  A. Adgey,et al.  Acute phase of myocardial infarction. , 1971, Lancet.